Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
申请人:Anikin Alexey Vyacheslavovich
公开号:US20080207635A1
公开(公告)日:2008-08-28
The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use.
本发明提供了能够调节酪氨酸激酶的化合物,包括这些化合物的组合物和使用它们的方法。
Heterocyclic compounds as TrkA modulators
申请人:ChemBridge Corporation
公开号:EP2298770A1
公开(公告)日:2011-03-23
The present invention provides compounds capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use.
本发明提供了能够调节酪氨酸激酶的化合物、包含这些化合物的组合物及其使用方法。
HETEROCYCLIC COMPOUNDS AS TYROSINE KINASE MODULATORS
申请人:ChemBridge Research Laboratories, Inc.
公开号:EP1960382A1
公开(公告)日:2008-08-27
US8629147B2
申请人:——
公开号:US8629147B2
公开(公告)日:2014-01-14
[EN] HETEROCYCLIC COMPOUNDS AS TYROSINE KINASE MODULATORS<br/>[FR] COMPOSES HETEROCYCLIQUES UTILES COMME MODULATEURS DES TYROSINE KINASES
申请人:CHEMBRIDGE RES LAB INC
公开号:WO2007056155A1
公开(公告)日:2007-05-18
[EN] The present invention provides compounds (1) to (6) capable of modulating tyrosine kinases, compositions comprising the compounds and methods of their use (Formulaes I to VI). [FR] La présente invention concerne des composés (1) à (6) capables de moduler des tyrosine kinases, des compositions comprenant ces composés et des procédés pour leur utilisation.